Crescent Biopharma, Inc. (CBIO)
11.65
-0.09
(-0.77%)
USD |
NASDAQ |
Feb 20, 16:00
11.67
+0.02
(+0.17%)
After-Hours: 20:00
Crescent Biopharma Market Cap : 354.71M for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| XOMA Royalty Corp. | 319.61M |
| Viridian Therapeutics, Inc. | 2.619B |
| DiaMedica Therapeutics, Inc. | 438.49M |
| Denali Therapeutics, Inc. | 3.153B |
| Praxis Precision Medicines, Inc. | 8.384B |
Market Cap Related Metrics
| Price to Book Value | 3.149 |
| Price | 11.65 |
| Earnings Yield | -188.6% |